Rad Onc @UTSW_RadOnc | Lymph/Peds/Sarc | Residency PD #MedEd | @StanfordRadOnc @BerkeleyHaas @UChicagoMed @UArizona Alum | AZ Sports Fan | Mixologist. Views=me

Joined April 2017
24 Photos and videos
Kiran A. Kumar, MD, MBA retweeted
A recent publication in Advances in Radiation Oncology, led by Drs. Holly Grace and @AsalRahimiMD, describes two dermatologic conditions that may occur in patients following radiation therapy for breast cancer. 📖: bit.ly/4dgypFz
3
14
770
Kiran A. Kumar, MD, MBA retweeted
Join us for our rotation blocks. Registration is now open! Register and learn more here ➡️: bit.ly/4dUpCep
5
10
3,349
My first clinical trial! While was just short of our hypothesis that early salvage ISRT after CAR-T can double CR rate from d30 to d90 PET, interesting subset and translative analyses forthcoming for when this could be great salvage option post-CAR-T (e.g. single site of PR)…
During a session on clinical trials shaping the future of RT, Dr. @kakumar86 presented his work, “Phase II Trial of ‘Re-Priming’ Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after CAR-T Therapy.” #ASTRO25
3
6
48
5,996
Huge thx to mentor/colleague/great friend @ndesai2005 who helped design & execute this all, as well @IyengarPuneeth & @BobTimmermanMD for mentorship/support, & everyone else @UTSW_RadOnc! Full abstract here (manuscript coming soon): doi.org/10.1016/j.ijrobp.202…

1
6
272
I swear there were people there (just empty front row)! Happy to have presented our pos phase II clinical trial results from PROMISE, which has revolutionized our ability to safely (with built in gating as safety mech) treat young children (3-7) without sedation! #ASTRO25
To close out a day of fantastic research, our Chief of Peds and Lymphoma Radiation Oncology Services, Dr. @kakumar86 presented his work during the Best of Physics session about the PROMISE clinical trial to reduce anesthesia use in pediatric patients undergoing RT. #ASTRO25
2
3
33
4,968
Very proud of @KhashiFattah for being one of four 2025 ROI award winners and being featured on the big stage at #ASTRO2025! @UTSW_RadOnc residents (only a PGY-2 at that) doing big things 👏🏾 @BobTimmermanMD @MonaArbabMD
Congratulations to Dr.@KhashiFattah! Dr. Fattah is a medical resident in our department.
1
9
28
6,061
Kiran A. Kumar, MD, MBA retweeted
Congratulations to Dr.@KhashiFattah! Dr. Fattah is a medical resident in our department.
Congratulations to the #ASTRO25 ROI Innovation Award winners: - Carmen Bergom, MD, PhD - Khashayar Fattah, MD - Michelle Iocolano, MD - Sue Yom, MD, PhD, MAS, FASTRO @carmenbergom @KhashiFattah @BobTimmermanMD @Michelleiocolan @johnplastaras @sueyom
1
15
6,068
Kiran A. Kumar, MD, MBA retweeted
Do you have an interest in radiation oncology? Join our Virtual Meet and Greet next Wednesday! You'll have the opportunity talk with some of our faculty and medical residents about our medical residency program! Zoom link🔗: bit.ly/46bdKQU
1
4
11
1,141
Kiran A. Kumar, MD, MBA retweeted
Join us for the second PULSAR Consortium Meeting at @ASTRO_org on Monday, September 29, at 6 p.m! This special meeting will feature in-depth discussions with leading experts on PULSAR in clinical practice. Register and learn more in the link below. 🔗: bit.ly/3Vng68X
1
13
22
2,594
An awesome group of faculty just got even better- welcome to @UTSW_RadOnc @AEwongwoMD @LinLZhu @MAliruMDPhD & @AkritaMDPhD! Love that our colleagues are also great friends, always fun celebrating good times with y’all! 🥳
Never need a reason to throw a party, but 4 new faculty is a good cause for celebration 🎉 Welcome to UTSW Rad Onc @AEwongwoMD, @MAliruMDPhD, @LinLZhu & @AkritaMDPhD 👑!
2
24
3,841
Innovative educator by day, HH bff by night 👩🏻‍🏫 🍸 Another great video for residents/students/all, make sure to check out! 💯
GI Pathology 101! For each subsite, we go through path basics – histology, IHC & molecular markers, key features from resection specimen & more. I ask @SuntreaHammer to explain path slides to me like I’m a 5-year-old 😀 Here's Part 1: CRC Full video link & slides below🧵1/4:
1
1
20
3,191
Kiran A. Kumar, MD, MBA retweeted
Congratulations to graduating medical resident Dr. @MihailoMiljanic, who received the David A. Pistenmaa Award!
1
2
18
853
Kiran A. Kumar, MD, MBA retweeted
As you take the next step in your careers, we celebrate the incredible journey of our graduating medical residents! Your commitment to excellence and patient care has been truly inspiring. Congratulations and best wishes for what lies ahead!
1
4
29
4,748
Congrats to our rising PGY-4 Brett Tortelli for being named one of the four 2025 ARRO-ASTRO Global Health Scholars 👏🏾 He has an awesome global health research year planned and this is just one of many awards/grants he’s received 💯 @UTSW_RadOnc
23 Jun 2025
Announcing the 2025 ARRO-ASTRO Global Health Scholars! CONGRATULATIONS! Dr. Bethel Adefres – Yale New Haven Hospital Dr. Kara Banson – NYU Langone Health Dr. Kelly Becht – Yale School of Medicine Dr. Brett Tortelli – UT Southwestern Medical Center
2
23
2,340
Kiran A. Kumar, MD, MBA retweeted
Congratulations to our PGY3, Dr. Brett Tortelli! We can’t wait to see all the amazing research you will continue to do. @UTSW_RadOnc
23 Jun 2025
Announcing the 2025 ARRO-ASTRO Global Health Scholars! CONGRATULATIONS! Dr. Bethel Adefres – Yale New Haven Hospital Dr. Kara Banson – NYU Langone Health Dr. Kelly Becht – Yale School of Medicine Dr. Brett Tortelli – UT Southwestern Medical Center
3
11
1,301
Kiran A. Kumar, MD, MBA retweeted
Congrats to our 5 graduating residents: Drs. Maureen Aliru, Ahmed Elamir, Meng-Lun Hsieh, Misha Miljanic, & Steven Montalvo. Great doctors & even better people! (Graduation was early this year, meaning we get another month w these awesome seniors). Gonna miss them so much ❤️
3
7
60
4,407
Congrats to our two stellar @UTSW_RadOnc med students Katherine and Ethan on graduating today! Really proud of them for their successes and happy to see the tradition of matching @HarvardRadOnc continuing 🥹🥂🥳
2
3
45
6,536
Would argue that lymphomas are one of the most important diseases to consider adaptive RT as they are exquisitely radiosensitive, often in difficult to target locations, and many have long term survival so even small decreases in dose to OARs are likely meaningful. Excited… 1/2
15 May 2025
Adaptive RT in lymphomas ➡️ better targeting w/ reduced margins, deceased dose to OARs, adaptation to shrinking tumors, shorter course treatments, & easier treatments of multi-targets/SIBs. Read @kakumar86 @UTSW_RadOnc et al's article in the #RedJournal: tinyurl.com/kumarrj
4
9
49
5,944
To share our @UTSW_RadOnc experience of >70 lymphomas showing that oART was necessary to maintain PTV coverage with smaller margins and that tumors shrank on average 25% during RT. Safer and shorter course treatment options will hopefully expand the use of RT in lymphomas⚡️🤞🏾 2/2
7
239
Nice job by one of our ⭐️ @UTSW_RadOnc med students @JuliaJShi showing dosi advantage with oART for H&N cancers! 👏🏾Adapt-on-demand provides flexibility and potential sig advantages over conventional RT @DavidSherMD @DominicMoonMD @VladAvkshtol
18 Apr 2025
Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study by @davidshermd et al. Read about it in the #RedJournal: tinyurl.com/redsher1
2
6
25
2,364